HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher N Mayhew Selected Research

Retinoblastoma (Glioblastoma, Retinal)

4/2008RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher N Mayhew Research Topics

Disease

5Neoplasms (Cancer)
06/2014 - 07/2004
4Carcinogenesis
04/2022 - 09/2007
3Gaucher Disease (Gaucher's Disease)
06/2023 - 01/2015
3Infections
12/2014 - 11/2002
3Murine Acquired Immunodeficiency Syndrome (MAIDS)
01/2005 - 11/2002
2Neuroinflammatory Diseases
06/2023 - 10/2019
2Fatty Liver
01/2019 - 06/2018
2Fanconi Anemia (Fanconi's Anemia)
01/2016 - 10/2014
2Hepatocellular Carcinoma (Hepatoma)
06/2014 - 05/2010
2Hypergammaglobulinemia (Hyperimmunoglobulinemia)
06/2004 - 11/2002
2Splenomegaly
06/2004 - 11/2002
1Parkinson Disease (Parkinson's Disease)
06/2023
1Cholestasis
04/2022
1Liver Failure
04/2022
1Cystic Fibrosis (Mucoviscidosis)
12/2021
1Inflammation (Inflammations)
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Inborn Genetic Diseases (Disease, Hereditary)
06/2018
1Hepatomegaly
06/2014
1Congenital Malabsorptive Diarrhea 4
02/2011
1Diabetes Mellitus
02/2010
1Retinoblastoma (Glioblastoma, Retinal)
04/2008
1Virus Diseases (Viral Diseases)
06/2004
1Aneuploidy (Aneuploid)
05/2004
1Nijmegen Breakage Syndrome
04/2004
1Disease Progression
11/2002
1Retroviridae Infections (Infection, Retrovirus)
11/2002

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
01/2016 - 11/2002
5AcidsIBA
06/2023 - 11/2002
3GlucosidasesIBA
06/2023 - 01/2015
3Proteins (Proteins, Gene)FDA Link
10/2014 - 04/2004
33,4,5-trihydroxybenzamidoximeIBA
01/2005 - 11/2002
33,4-dihydroxybenzohydroxamic acidIBA
01/2005 - 11/2002
2CarcinogensIBA
10/2011 - 09/2007
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2005 - 11/2002
2Hydroxyurea (Hydrea)FDA LinkGeneric
01/2005 - 11/2002
1Nerve Growth Factors (Neurotrophins)IBA
06/2023
1SynucleinsIBA
06/2023
1Zonula Occludens-2 ProteinIBA
04/2022
1Mutant Proteins (Protein, Mutant)IBA
12/2021
1Glial Fibrillary Acidic ProteinIBA
10/2019
1Messenger RNA (mRNA)IBA
10/2019
1Sterol Esterase (Hormone-Sensitive Lipase)IBA
01/2019
1Nonesterified Fatty Acids (NEFA)IBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Virulence Factors (Pathogenicity Factors)IBA
12/2014
1XenobioticsIBA
06/2014
1Peroxisome ProliferatorsIBA
06/2014
1Benzene (Benzole)IBA
06/2014
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
10/2011
1Transcription Factors (Transcription Factor)IBA
02/2011
1palbociclibIBA
05/2010
1Insulin (Novolin)FDA Link
02/2010
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
04/2008
1Transforming Growth Factor beta (TGF-beta)IBA
04/2008
1Transforming Growth Factor beta3 (TGF beta 3)IBA
04/2008
1Antiviral Agents (Antivirals)IBA
01/2005
1Didanosine (Videx)FDA LinkGeneric
01/2005
1Polo-Like Kinase 1IBA
07/2004
1GuanineIBA
06/2004
1abacavir (Ziagen)FDA Link
06/2004
1AntimetabolitesIBA
05/2004
1Free RadicalsIBA
11/2002

Therapy/Procedure

4Therapeutics
12/2021 - 11/2002
2Transplantation
10/2019 - 02/2010
1Intravenous Infusions
10/2019
1Radio Frequency Identification Device
06/2018